Forte Biosciences Inc. (NASDAQ: FBRX)
$0.56
+0.0020 ( +0.36% ) 22.1K
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Market Data
Open
$0.56
Previous close
$0.56
Volume
22.1K
Market cap
$21.14M
Day range
$0.57 - $0.59
52 week range
$0.38 - $1.03
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 20, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
4 | Insider transactions | 1 | Sep 20, 2023 |
ars | Annual reports | 1 | Aug 24, 2023 |
10-q | Quarterly Reports | 58 | Aug 14, 2023 |
8-k | 8K-related | 13 | Aug 04, 2023 |